Meanwhile, CCL5-neutralizing antibody at 1 μg/mL also decreased the number of cancer cells in the culture medium with 10% FBS (a decreasing trend was observed, but statistical significance was not reached in the HCT-116 cells) ( Figure 10 ).
← all excerpts
Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells.
1
—
—